Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin.

Pooled human immunoglobulin suitable for intravenous administration (IGIV) was evaluated in the prophylaxis and treatment of herpes simplex virus (HSV) type 1 encephalitis in a murine model. Four-week-old BALB/c mice received a single intraperitoneal injection of IGIV or saline 24 h before or up to...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Erlich, K S, Dix, R D, Mills, J
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1987
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174861/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2821882/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.7.1006
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!